IP Library Granted Patent US 8,354,129
Granted Patent B2
US 8,354,129 · App. 09/850,804 · Granted Jan 15, 2013

Vitamin containing product

Inventors: Paul Thomas Quinlan (Sharnbrook, GB); Cees Vermeer (Maastricht, NL)
Assignee: Nattopharm ASA
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,354,129
App. No.
09/850,804
Granted
Jan 15, 2013
Kind
B2
Abstract

A food product comprising menaquinone at a level of 50 to 5,000 μg per 100 g of product.

Claims (18)

1. A method for promoting cardiovascular health, comprising providing a food product which is not an egg, the food product containing vitamin K, wherein the total amount of vitamin K in the food product predominantly comprises menaquinone in an amount of 50 to 200 mcg per 100 g of product, with the proviso that if the menaquinone is a MK-n menaquinone, wherein n≧4, then the food product is not a cheese or natto.

2. A method according to claim 1 wherein the food product is not a highly proteinaceous food product such as meat, fish, or dairy product.

3. A method according to claim 1 , wherein the food product is selected from the group of meal replacers, dietary supplements, ice-cream, sauces, dressing, spreads, bars, sweets, snacks, cereals and beverages.

4. A method according to claim 1 wherein the menaquinone level is from 50 to 100 mcg per 100 g product.

5. A method according to claim 1 wherein the menaquinone is a MK-4 menaquinone.

6. A method according to claim 1 further comprising one or more of calcium, vitamin D, or magnesium.

7. A method for promoting cardiovascular health, comprising providing a food product which is not an egg, cheese or natto, and adding vitamin K to the food product so that the total amount of vitamin K in the food product consists essentially of menaquinone in an amount of 50 to 200 mcg per 100 g of product.

8. A method for promoting cardiovascular health, comprising providing a food product containing vitamin K, wherein the food product is selected from the group of meal replacers, dietary supplements, ice-cream, sauces, dressing, margarine, bars, sweets, snacks, cereals and beverages, and the total amount of vitamin K in the food product consists essentially of menaquinone at a level of 50 to 200 mcg per serving.

9. A method according to claim 8 wherein the menaquinone level is from 50 to 100 mcg per serving.

10. A method according to claim 8 wherein the menaquinone is a MK-4 menaquinone.

11. A method according to claim 8 further comprising one or more of calcium, vitamin D, or magnesium.

12. A method for promoting cardiovascular health, comprising providing a food product containing vitamin K, wherein the food product is selected from the group of meal replacers, dietary supplements, ice-cream, sauces, dressing, margarine, bars, sweets, snacks, cereals and beverages, and adding an amount of vitamin K2 to the food product so that the total amount of vitamin K in the food product consists essentially of menaquinone at a level of 50 to 200 mcg per serving.

13. A method for promoting cardiovascular health of an individual comprising providing a food product containing vitamin K, wherein the total amount of vitamin K in the food product consists only of 50 to 200 mcg of menaquinone.

14. A method for promoting cardiovascular health of an individual according to claim 13 , wherein the food product contains 50 mcg of menaquinone and is consumed once daily by the individual.

15. A method for promoting cardiovascular health according to claim 13 , wherein the food product consists of 50 to 200 mcg of menaquinone per 100 grams of product or per serving and is consumed once daily by the individual.

16. A method for promoting cardiovascular health of an individual comprising providing a food product that does not contain vitamin K, and incorporating 50 to 200 mcg of menaquinone into the food product so that the food product contains only vitamin K2 as the source of vitamin K.

17. A method for promoting cardiovascular health of an individual comprising providing a food product that does not contain vitamin K, and incorporating 5 to 200 mcg of menaquinone into the food product so that the food product contains only vitamin K2 as the source of vitamin K.

18. A method for promoting cardiovascular health, comprising providing a food product which his not an egg, natto, or cheese, the food product containing vitamin K, wherein the total amount of vitamin K in the food product predominantly comprises menaquinone in an amount of 5 to 200 mcg 100 g of product.

Assignments (7)
CHANGE OF NAME Recorded Dec 20, 2022
From: PHARMACO AS
To: KAYDENCE PHARMA AS
Reel/Frame 062160/0444 →
MERGER Recorded Dec 20, 2022
From: KAYDENCE PHARMA AS
To: NATTOPHARMA AS
Reel/Frame 062160/0480 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2018
From: NATTOPHARMA ASA
To: PHARMACO AS
Reel/Frame 044738/0241 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2012
From: VERMEER, CEES
To: NATTOPHARMA ASA
Reel/Frame 029458/0485 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2007
From: VITAK B.V.
To: NATTOPHARMA ASA
Reel/Frame 019234/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2004
From: LIPTON DIVISION OF CONOPCO, INC.
To: VITAK B.V.
Reel/Frame 015061/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2001
From: QUINLAN, PAUL THOMAS
To: LIPTON, DIVISION OF CONOPCO, INC.
Reel/Frame 012146/0965 →
Priority Claims (1)
EP 00303995 · May 12, 2000 · regional
Continuity (1)
Related Publication 20020015762A1 · Feb 7, 2002